| 1 |
Tom Hosack, Djamil Damry, Sujata Biswas. Drug-induced liver injury: a comprehensive review. Therap Adv Gastroenterol 2023;16:17562848231163410. [ DOI: 10.1177/17562848231163410] [Reference Citation Analysis]
|
| 2 |
Méndez-sánchez N, Teschke R. Drug-induced liver injury caused by conventional drugs, using cases based on the Roussel Uclaf causality assessment method. Comprehensive Guide to Hepatitis Advances 2023. [DOI: 10.1016/b978-0-323-98368-6.00002-1] [Reference Citation Analysis]
|
| 3 |
Teschke R. Treatment of Drug-Induced Liver Injury. Biomedicines 2022;11. [PMID: 36672522 DOI: 10.3390/biomedicines11010015] [Reference Citation Analysis]
|
| 4 |
Malnick SDH, Alin P, Somin M, Neuman MG. Fatty Liver Disease-Alcoholic and Non-Alcoholic: Similar but Different. Int J Mol Sci 2022;23. [PMID: 36555867 DOI: 10.3390/ijms232416226] [Reference Citation Analysis]
|
| 5 |
Malnick S, Maor Y, Neuman MG. Green Tea Consumption Is Increasing but There Are Significant Hepatic Side Effects. GastroHep 2022;2022:1-5. [DOI: 10.1155/2022/2307486] [Reference Citation Analysis]
|
| 6 |
Kawase A, Takashima O, Tanaka S, Shimada H, Iwaki M. Diclofenac-Induced Cytotoxicity in Direct and Indirect Co-Culture of HepG2 Cells with Differentiated THP-1 Cells. IJMS 2022;23:8660. [DOI: 10.3390/ijms23158660] [Reference Citation Analysis]
|
| 7 |
Woo SM, Alhaqqan DM, Gildea DT, Patel PA, Cundra LB, Lewis JH. Highlights of the drug-induced liver injury literature for 2021. Expert Rev Gastroenterol Hepatol 2022;16:767-85. [PMID: 35839342 DOI: 10.1080/17474124.2022.2101996] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Krarup KB, Rantanen JM, Mørk M, Pedersen IS, Christensen JH, Kristensen SR, Handberg A, Krarup HB. The Physiological and Cardiologic Effects of Long Video Gaming Sessions in Adult Males. Sports Med Int Open 2022;6:E39-46. [PMID: 35874049 DOI: 10.1055/a-1858-8436] [Reference Citation Analysis]
|
| 9 |
Xu H, Wang H. Immune cells in alcohol-related liver disease. Liver Research 2022. [DOI: 10.1016/j.livres.2022.01.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 10 |
Teschke R, Vongdala N, Quan NV, Quy TN, Xuan TD. Metabolic Toxification of 1,2-Unsaturated Pyrrolizidine Alkaloids Causes Human Hepatic Sinusoidal Obstruction Syndrome: The Update. Int J Mol Sci 2021;22:10419. [PMID: 34638760 DOI: 10.3390/ijms221910419] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 11 |
Teschke R, Xuan TD. Suspected herb induced liver injury by green tea extracts: Critical review and case analysis applying RUCAM for causality assessment.Japanese J Gastroenterol Hepatol. 2019;6:1-16. [DOI: 10.21037/tgh-20-149] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 12 |
Na AY, Jo JJ, Kwon OK, Cho P, Gao Y, Kim JH, Kim KM, Ki SH, Lee S. Characterization of hyperglycemia due to sub-chronic administration of red ginseng extract via comparative global proteomic analysis. Sci Rep 2021;11:12374. [PMID: 34117292 DOI: 10.1038/s41598-021-91664-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 13 |
Umbaugh DS, Jaeschke H. Biomarkers of drug-induced liver injury: a mechanistic perspective through acetaminophen hepatotoxicity. Expert Rev Gastroenterol Hepatol 2021;15:363-75. [PMID: 33242385 DOI: 10.1080/17474124.2021.1857238] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 14 |
Teschke R, Uetrecht J. Mechanism of idiosyncratic drug induced liver injury (DILI): unresolved basic issues. Ann Transl Med 2021;9:730. [PMID: 33987428 DOI: 10.21037/atm-2020-ubih-05] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 15 |
Teschke R, Danan G. Idiosyncratic Drug-Induced Liver Injury (DILI) and Herb-Induced Liver Injury (HILI): Diagnostic Algorithm Based on the Quantitative Roussel Uclaf Causality Assessment Method (RUCAM). Diagnostics (Basel) 2021;11:458. [PMID: 33800917 DOI: 10.3390/diagnostics11030458] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 16 |
Teschke R, Danan G. Worldwide Use of RUCAM for Causality Assessment in 81,856 Idiosyncratic DILI and 14,029 HILI Cases Published 1993-Mid 2020: A Comprehensive Analysis. Medicines (Basel) 2020;7:E62. [PMID: 33003400 DOI: 10.3390/medicines7100062] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 11.7] [Reference Citation Analysis]
|
| 17 |
Teschke R, Zhu Y, Jing J. Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases. J Clin Transl Hepatol 2020;8:200-14. [PMID: 32832401 DOI: 10.14218/JCTH.2020.00009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 18 |
Neuman MG, Seitz HK, French SW, Malnick S, Tsukamoto H, Cohen LB, Hoffman P, Tabakoff B, Fasullo M, Nagy LE, Tuma PL, Schnabl B, Mueller S, Groebner JL, Barbara FA, Yue J, Nikko A, Alejandro M, Brittany T, Edward V, Harrall K, Saba L, Mihai O. Alcoholic-Hepatitis, Links to Brain and Microbiome: Mechanisms, Clinical and Experimental Research. Biomedicines 2020;8:E63. [PMID: 32197424 DOI: 10.3390/biomedicines8030063] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
